Gouws Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Gouws Capital's AMGN Position: Q3 2026 in Review
Gouws Capital reduced its Amgen (AMGN) stake by 33% in Q3 2026, selling an estimated $797K and leaving 4,100 shares worth $1.73M. The position accounts for 0.82% of the portfolio, ranked #23.
Gouws Capital first reported a position in AMGN in Q4 2021 and has held it in 20 quarters since. The position peaked at $5.37M in Q3 2024. 3,119 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Gouws Capital held 4,100 shares of Amgen worth $1.73M as of Q3 2026.
- Gouws Capital sold 2,000 Amgen shares in Q3 2026, an estimated $797K.
- Amgen made up 0.82% of Gouws Capital's portfolio in Q3 2026, its #23 holding.
- Gouws Capital first reported a position in Amgen in Q4 2021 and has held it in 20 quarters since.
- Gouws Capital's Amgen position peaked at $5.37M in Q3 2024.
- 3,119 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Gouws Capital's 13F filing for Q3 2026, filed 9 Oct 2026.